Skip to main content

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Blueprint Medicines Corp changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of BPMC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders2486237−5
Shares59.8M105.2K63.2M+3.45M (+5.8%)
Value$3.82B$6.72M$3.19B−$623.5M (−16.3%)

6 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Blueprint Medicines Corp at the end of Q2 2022 but not at the end of Q1 2022.

Sold out (39)

Institutions that held Blueprint Medicines Corp at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (6)

Institutions that held Blueprint Medicines Corp at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BPMC in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC50,770$3.24M
Susquehanna Fundamental Investments, LLC17,174$1.10M
Virginia Retirement Systems Et Al15,800$1.01M
Teachers Retirement System of the State of Kentucky12,039$769.0K
Amalgamated Financial Corp.9,415$601.0K
SJS Investment Consulting Inc.1$0